Tami Annable

1.3k total citations
23 papers, 1.0k citations indexed

About

Tami Annable is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Tami Annable has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Cell Biology. Recurrent topics in Tami Annable's work include Microtubule and mitosis dynamics (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Liver physiology and pathology (4 papers). Tami Annable is often cited by papers focused on Microtubule and mitosis dynamics (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Liver physiology and pathology (4 papers). Tami Annable collaborates with scholars based in United States and China. Tami Annable's co-authors include Lee M. Greenberger, Sridhar K. Rabindran, Manu Smriti Singh, H He, Frank Loganzo, Eric Brown, Sylvia Musto, Xingzhi Tan, Malathi Hari and Tito Fojo and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Biochemistry.

In The Last Decade

Tami Annable

23 papers receiving 983 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tami Annable United States	17	571	459	157	130	127	23	1.0k
C.R. Fairchild United States	11	664 1.2×	733 1.6×	167 1.1×	87 0.7×	108 0.9×	12	1.1k
Dale Grabowski United States	22	1.1k 1.9×	650 1.4×	128 0.8×	106 0.8×	157 1.2×	67	1.4k
Leonard Lothstein United States	20	978 1.7×	890 1.9×	187 1.2×	164 1.3×	79 0.6×	37	1.6k
Elizabeth Hopper-Borge United States	18	638 1.1×	954 2.1×	102 0.6×	132 1.0×	83 0.7×	20	1.5k
Lela Buckingham United States	17	505 0.9×	353 0.8×	56 0.4×	122 0.9×	71 0.6×	48	983
Robert C.A.M. van Waardenburg United States	20	860 1.5×	589 1.3×	40 0.3×	100 0.8×	144 1.1×	38	1.2k
Hemant Parekh United States	16	430 0.8×	323 0.7×	150 1.0×	91 0.7×	129 1.0×	37	773
Shama Kajiji United States	14	372 0.7×	497 1.1×	229 1.5×	75 0.6×	41 0.3×	23	1.1k
Zizheng Dong United States	25	1.2k 2.1×	488 1.1×	57 0.4×	348 2.7×	62 0.5×	49	1.6k
DB Longley United Kingdom	2	778 1.4×	552 1.2×	73 0.5×	285 2.2×	70 0.6×	3	1.3k

Countries citing papers authored by Tami Annable

Since Specialization

Citations

This map shows the geographic impact of Tami Annable's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tami Annable with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tami Annable more than expected).

Fields of papers citing papers by Tami Annable

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tami Annable. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tami Annable. The network helps show where Tami Annable may publish in the future.

Co-authorship network of co-authors of Tami Annable

This figure shows the co-authorship network connecting the top 25 collaborators of Tami Annable. A scholar is included among the top collaborators of Tami Annable based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tami Annable. Tami Annable is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Nan, Kelly McDaniel, Tianhao Zhou, et al.. (2018). Knockout of microRNA-21 attenuates alcoholic hepatitis through the VHL/NF-κB signaling pathway in hepatic stellate cells. American Journal of Physiology-Gastrointestinal and Liver Physiology. 315(3). G385–G398. 26 indexed citations

Wan, Ying, Kelly McDaniel, Nan Wu, et al.. (2017). Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury. American Journal Of Pathology. 187(12). 2788–2798. 68 indexed citations

McDaniel, Kelly, Li Huang, Keisaku Sato, et al.. (2017). The let-7/Lin28 axis regulates activation of hepatic stellate cells in alcoholic liver injury. Journal of Biological Chemistry. 292(27). 11336–11347. 57 indexed citations

Wan, Ying, Yuyan Han, Kelly McDaniel, et al.. (2015). 236 miR-34a Regulates Cellular Senescence in Activated Hepatic Stellate Cells During Alcohol Induced Hepatic Injury. Gastroenterology. 148(4). S–974. 2 indexed citations

Wan, Ying, Nan Wu, Yuyan Han, et al.. (2015). Role of stem cells during diabetic liver injury. Journal of Cellular and Molecular Medicine. 20(2). 195–203. 24 indexed citations

Annable, Tami, et al.. (2014). Using Poly I:C as an adjuvant does not induce or exacerbate models of systemic lupus erythematosus. Autoimmunity. 48(1). 29–39. 8 indexed citations

Payne, Joseph E., Céline Bonnefous, Christian A. Hassig, et al.. (2008). Identification of KD5170: A novel mercaptoketone-based histone deacetylase inhibitor. Bioorganic & Medicinal Chemistry Letters. 18(23). 6093–6096. 21 indexed citations

Wash, Paul L., Timothy Z. Hoffman, Brandon M. Wiley, et al.. (2008). α-Mercaptoketone based histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(24). 6482–6485. 7 indexed citations

Hari, Malathi, Frank Loganzo, Tami Annable, et al.. (2006). Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of β-tubulin (Asp26Glu) and less stable microtubules. Molecular Cancer Therapeutics. 5(2). 270–278. 120 indexed citations

10.

Annable, Tami, et al.. (2006). Combination therapy for treating breast cancer using antiestrogen, ERA-923, and the mammalian target of rapamycin inhibitor, temsirolimus. Endocrine Related Cancer. 13(3). 863–873. 30 indexed citations

11.

Loganzo, Frank, Malathi Hari, Tami Annable, et al.. (2004). Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulin.. PubMed. 3(10). 1319–27. 25 indexed citations

12.

Yamashita, Ayako, Joshua A. Kaplan, Frank Loganzo, et al.. (2004). Synthesis and activity of novel analogs of hemiasterlin as inhibitors of tubulin polymerization: modification of the A segment. Bioorganic & Medicinal Chemistry Letters. 14(21). 5317–5322. 16 indexed citations

13.

Discafani, Carolyn, Carl F. Beyer, Tami Annable, et al.. (2004). 524 MST-997: a novel taxane with superior efficacy that overcomes paclitaxel and docetaxel resistance in vitro and in vivo. European Journal of Cancer Supplements. 2(8). 160–160. 1 indexed citations

14.

Loganzo, Frank, Malathi Hari, Tami Annable, et al.. (2004). Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in α-tubulin. Molecular Cancer Therapeutics. 3(10). 1319–1327. 24 indexed citations

15.

Poruchynsky, Marianne S., Jong-Hyeok Kim, Eva Nogales, et al.. (2004). Tumor Cells Resistant to a Microtubule-Depolymerizing Hemiasterlin Analogue, HTI-286, Have Mutations in α- or β-Tubulin and Increased Microtubule Stability. Biochemistry. 43(44). 13944–13954. 48 indexed citations

16.

Loganzo, Frank, Carolyn Discafani, Tami Annable, et al.. (2003). HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo.. PubMed. 63(8). 1838–45. 97 indexed citations

17.

Greenberger, Lee M., Tami Annable, Barry S. Komm, et al.. (2001). A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.. PubMed. 7(10). 3166–77. 39 indexed citations

18.

Rabindran, Sridhar K., H He, Manu Smriti Singh, et al.. (1998). Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C.. PubMed. 58(24). 5850–8. 262 indexed citations

19.

Greenberger, Lee M., Tami Annable, Joseph Boni, et al.. (1996). alpha-(3,4-dimethyoxyphenyl)-3,4-dihydro-6,7-dimethoxy-alpha- [(4-methylphenyl)thio]-2(1H)-isoquinolineheptanenitrile (CL 329,753): a novel chemosensitizing agent for P-glycoprotein-mediated resistance with improved biological properties compared with verapamil and cyclosporine A.. PubMed. 8(5). 207–18. 8 indexed citations

20.

Ritke, M K, Jack C. Yalowich, Marilyn L. Slovak, et al.. (1994). P-glycoprotein mediates profound resistance to bisantrene.. PubMed. 6(7). 291–301. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact